Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial
- 1 February 2015
- journal article
- research article
- Published by Elsevier BV in The Lancet HIV
- Vol. 2 (2), e52-e63
- https://doi.org/10.1016/s2352-3018(14)00032-0
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1 UL1 RR025758-04, 5K24HL113128, 5T32HL076136, K23HL092792, P30 DK040561, R01HL095123)
- National Center for Research Resources
- Harvard Catalyst
This publication has 49 references indexed in Scilit:
- Natural History of Coronary Atherosclerosis by Multislice Computed TomographyJACC: Cardiovascular Imaging, 2012
- Effect of Two Intensive Statin Regimens on Progression of Coronary DiseaseThe New England Journal of Medicine, 2011
- Prognostic Implications of Nonobstructive Coronary Plaques in Patients With Non–ST-Segment Elevation Myocardial Infarction: A Multidetector Computed Tomography StudyJournal of the American College of Cardiology, 2011
- High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical TrialThe Journal of Infectious Diseases, 2011
- Normalization of automatic plaque quantification in cardiac computed tomography (CCT)International Journal of Cardiology, 2011
- Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studiesThe Lancet, 2010
- Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected menAIDS, 2010
- Low-Dose Physiological Growth Hormone in Patients With HIV and Abdominal Fat AccumulationJama-Journal Of The American Medical Association, 2008
- Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus DiseaseJournal of Clinical Endocrinology & Metabolism, 2007
- Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitorsAmerican Heart Journal, 2004